Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0NY6U
|
|||
Former ID |
DIB019388
|
|||
Drug Name |
PMID24673130C26
|
|||
Synonyms |
GTPL8134; BDBM50011536
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C13H9FN4
|
|||
Canonical SMILES |
C1=CC(=CC(=C1)F)C2=NC3=C(C=C2)N=CN=C3N
|
|||
InChI |
1S/C13H9FN4/c14-9-3-1-2-8(6-9)10-4-5-11-12(18-10)13(15)17-7-16-11/h1-7H,(H2,15,16,17)
|
|||
InChIKey |
TWTLUQDFSDYZKO-UHFFFAOYSA-N
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | MEK kinase kinase 4 (MAP4K4) | Target Info | Inhibitor | [1] |
NetPath Pathway | FSH Signaling Pathway | |||
TCR Signaling Pathway | ||||
Panther Pathway | Apoptosis signaling pathway | |||
Pathway Interaction Database | EPHB forward signaling | |||
TNF receptor signaling pathway | ||||
Ceramide signaling pathway | ||||
Direct p53 effectors | ||||
Reactome | Oxidative Stress Induced Senescence | |||
WikiPathways | Insulin Signaling | |||
MAPK Signaling Pathway |
References | Top | |||
---|---|---|---|---|
REF 1 | Discovery of selective 4-Amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimization. J Med Chem. 2014 Apr 24;57(8):3484-93. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.